#3 Thromboinflammation, rivaroxaban, and extracellular vesicles with Luisa Weiss

episode

Don't Just Read the Guidelines not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Transrapid, Flugtaxis, Hyperloop – Warum es neuartige Verkehrstechnik so schwer hat 28 min · 22 Sep 2026 · Das Wissen | SWR

NPR News: 09-21-2026 1PM EDT 5 min · 21 Sep 2026 · NPR News Now

1PM ET 09/21/2026 Newscast 3 min · 21 Sep 2026 · Fox News Hourly Update

The Invisible Front_ Geoeconomics and the New World Order 3 min · 21 Sep 2026 · Conspiracy Theories Exploring The Unseen

The Intellectual Glow Up: How To Think Deeper 29 min · 21 Sep 2026 · Two Broke Chicks

Why Listening Beats Every Argument 1h 44m · 21 Sep 2026 · The Jordan B. Peterson Podcast

Report any issue

Source

Recorded03 Aug 2021

Publisherfeeds.soundcloud.com ↗

Handlerec:3493634

Show notes

On this episode, I talk to Luisa Weiss who is a PhD student in Dublin, Ireland. Luisa's has recently published a very interesting paper in the Journal of Thrombosis and Haemostasis entitled: "Nonvalvular atrial fibrillation patients anticoagulated with rivaroxaban compared with warfarin exhibit reduced circulating extracellular vesicles with attenuated pro-inflammatory protein signatures" Here, we talk about the paper, further questions, and the clinical implications of her findings. The paper is available as an open access publication at https://onlinelibrary.wiley.com/doi/10.1111/jth.15434?af=R

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in